Curative Labs Inc

**** *** **** *** **

Washington, DC 20002

ad3bg2@r.postjobfree.com

Final Results Report

Patient Name: DAVILA, MONICA Facility: Arlington County Patient MRN: CUR152289455 Requisition: 59728501

Date of Birth: 07/14/1961 (61 years old) Kit ID: A305897759431 Sex: FEMALE Collected: 08/27/2022 02:19:18 PM EDT

Address: 1110 N KENSINGTON ST APT 7

ARLINGTON, VA 22205 Received: 08/27/2022 09:30:52 PM EDT Phone Number: 1-571-***-**** Released: 08/28/2022 02:35:03 AM EDT Email: ad3bg2@r.postjobfree.com Specimen Type: Alinity shallow nasal swab Physician: Zalzala, Sajad (163*******)

Test Result

SARS-CoV-2 Assay (RNA Detection Test by RT-PCR) Negative Interpretation:

Positive: SARS-CoV-2 RNA detected by RT-PCR

Negative: SARS-CoV-2 RNA not detected by RT-PCR

Indeterminate: Indeterminate for SARS-CoV-2 RNA by RT-PCR. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Inadequate sample collection or exposure to extreme heat during transport may decrease the ability to detect SARS-CoV-2 RNA in a sample. Negative results must be combined with clinical observations, patient history, and epidemiological information. Indeterminate results means that the test was not able to clearly determine whether SARS-CoV-2 was or was not present and may occur in the case of an inadequate specimen. Specimen must be recollected if test is still required. Method: Curative HT SARS-CoV-2 Test (Real-Time Reverse-Transcription PCR) This test is based on the CDC SARS-CoV-2 assay, a real-time reverse-transcription polymerase chain reaction (RT-PCR) test that detects RNA from SARS-CoV-2 in upper or lower respiratory specimens. The test has been optimized to be performed on the BioRad CFX Real-Time PCR detection system and uses high throughput technologies.

Disclaimer:

This SARS-CoV-2 PCR test was developed and its performance characteristics were determined by Curative Labs. This test has not been cleared, approved or authorized by the U.S. Food and Drug Administration (FDA). This test may be used for clinical purposes and should not be regarded as investigational or for research only. Curative Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Lab director: Arthur Baca MD, PhD; CLIA # 09D2180856; Sample reviewed at: 08/28/2022 02:05:03 AM EDT; Report generated at: 08/28/2022 10:52:06 AM EDT